{"first_name":"Rebecca","last_name":"Critchley-Thorne","permalink":"rebecca-critchley-thorne","crunchbase_url":"http://www.crunchbase.com/person/rebecca-critchley-thorne","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Unaffiliated","born_year":null,"born_month":null,"born_day":null,"tag_list":null,"alias_list":null,"created_at":"Mon Mar 12 11:24:34 UTC 2012","updated_at":"Mon Mar 12 11:55:48 UTC 2012","overview":"<p>Dr. Rebecca Critchley-Thorne is responsible for the development of novel cancer in vitro diagnostics based on Cernostics&#8217; proprietary Tissue Systems Pathology approach. She is a cancer immunologist with expertise in molecular and functional profiling of patient samples and was previously a Senior Scientist at Cellumen, Inc. in the Patient Sample Profiling Program, responsible for the collaborative project on breast cancer diagnostics with the Mayo Clinic.</p>","image":{"available_sizes":[[[116,150],"assets/images/resized/0017/7745/177745v1-max-150x150.jpg"],[[140,180],"assets/images/resized/0017/7745/177745v1-max-250x250.jpg"],[[140,180],"assets/images/resized/0017/7745/177745v1-max-450x450.jpg"]],"attribution":""},"degrees":[],"relationships":[{"is_past":false,"title":"Director of Biomarker & Diagnostic Development","firm":{"name":"Cernostics","permalink":"cernostics","type_of_entity":"company","image":{"available_sizes":[[[150,41],"assets/images/resized/0017/7738/177738v1-max-150x150.jpg"],[[250,69],"assets/images/resized/0017/7738/177738v1-max-250x250.jpg"],[[268,74],"assets/images/resized/0017/7738/177738v1-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}